You are here: Industry Insights > CRO

News List

Quanticate Appoints Chief Operating Officer contractpharma
February 04, 2021
Quanticate, a global data-focused Clinical Research Organization (CRO), has named Lee Patterson as the its chief operating officer (COO).
Parexel Completes Strategic Separation contractpharma
January 13, 2021
Parexel, a provider of drug development servicess from clinical through commercialization, has completed the separation of its Parexel Informatics and Medical Imaging business.
Ergomed Acquires MedSource contractpharma
December 16, 2020
Ergomed plc, a company focused on providing specialized services to the pharmaceutical industry, has acquired MS Clinical Services, LLC (MedSource), a specialized CRO based in Houston, TX, for an initial consideration of $16.2 million in cash at ...
GenNext at SIRO Clinpharm expresspharma
December 08, 2020
The COVID-19 pandemic has left its mark on the clinical research and trials sector, but disruptions have only served to temper the steel of long-timers.
Reach Separations Expands Nottingham Premises contractpharma
November 05, 2020
Early-stage drug discovery, purification specialist and contract research organization (CRO) Reach Separations has expanded its Nottingham premises in the wake of increased demand for its chiral purification services.
Syneos Health Agrees to Acquire Synteract contractpharma
October 30, 2020
Enhances Syneos Health’s position across the fast-growing small to mid-sized category.
Top six CROs on Japanese market revealed in new report europeanpharmaceuticalreview
October 09, 2020
Researchers have revealed the top six CROs that dominate the Japanese market and are expected to continue in their position.
Europital Launches as Full Service CRO contractpharma
September 24, 2020
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries.
Europital Opens New Site in Oxford contractpharma
August 27, 2020
Europital, a global provider of medical management services for clinical research and drug development, is opening a UK site to further expand its services to the UK biotech industry.
Lipidor Signs Agreement With CRO for Implementation of Phase III Clinical Study of Drug Candidate AKP-02 Against Psoriasis prnasia
July 08, 2020
Lipidor AB (Nasdaq First North: LIPI) today announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company with extensive CRO capacity, to conduct a Phase III study for Lipidor's drug candidate AKP-02. The study is expected to

Previous page 1 2 3 4 5 6 7 Next page